--- title: "Impact of QNS in Molecular Diagnostics: Pathways to Better Cancer Care" description: White paper on complementary molecular tumor profiling solutions to improve QNS rates, reduce TAT, and lower lab costs per sample. Download now! image: https://engage.agenabio.com/hubfs/Tumor-slides-1356011599-Feat-img-01.webp --- ![Agena Bioscience](https://engage.agenabio.com/hubfs/Agena-Bioscience-Logo-space-137x65-01t.png) # **WHITE PAPER:** Poor-Quality Samples, No NGS Data: Is There a Better Solution? ## Unlock More Results from Your FFPE Samples with the MassARRAY® System Did you know that up to 25% of samples submitted for NGS-based molecular testing fail due to sample quantity and quality issues? Lost results mean lost insights. But there’s a better way. ![FFPE Samples](https://engage.agenabio.com/hubfs/Untitled%20design%20(5).png) Discover how the iPLEX® HS Lung Panel on the MassARRAY System recovers results from challenging samples that fail NGS-based analysis. This targeted molecular profiling solution offers ultra-low DNA input requirements and a <2% failure rate, even with FFPE samples.  ### What You’ll Learn:  - **What common sample quality issues are affecting NGS data output** - **How mass spectrometry overcomes these challenges** - **Real-world study results demonstrating superior performance ** *Get the full insights—complete the form to receive the exclusive white paper and learn how you can stop losing precious samples to NGS quality issues.* ### ![Download-Doc-Icon-25x30-01](https://engage.agenabio.com/hubfs/Download-Doc-Icon-25x30-01.webp) Download Now Complete the form to receive the exclusive white paper on the challenges of QNS in molecular tumor profiling. ### About Agena Bioscience At Agena Bioscience, we are dedicated to advancing the impact of genomics in healthcare and precision medicine. ### Connect For Research Use Only. Not for use in diagnostic procedures. | © 2025 Agena Bioscience